Of the four patients who could be evaluated as of the Nov. 22 cutoff, three showed responses to the treatment, ADI-001, Adicet reported on Monday. Two of those patients achieved a complete response.

New! Sign up for our free email newsletter.

Beverly is a writer, editor, and paralegal specializing in personal finance and tax law. She covers personal financial and legal topics, as well as tax breaks, tax preparation software, and tax law ...

Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...